Monoclonal Antibody RX and Covid Variants

Most monoclonal antibody therapies that neutralized early variants of the SARS-CoV-2 virus are less effective or not effective against the BA.2.12.1, BA.4, and BA.5 Omicron subvariants that currently make up almost 99% of infections in the United States, according to a report in Nature.

Evolving Omicron Subvariants Are More Resistant to Antibody Therapy — https://jamanetwork.com/journals/jama/fullarticle/2795047

Oops.

6 thoughts on “Monoclonal Antibody RX and Covid Variants

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s